5.47
前日終値:
$5.37
開ける:
$5.39
24時間の取引高:
827.93K
Relative Volume:
0.21
時価総額:
$1.68B
収益:
$248.37M
当期純損益:
$11.74M
株価収益率:
109.40
EPS:
0.05
ネットキャッシュフロー:
$18.24M
1週間 パフォーマンス:
+2.55%
1か月 パフォーマンス:
+19.08%
6か月 パフォーマンス:
+10.42%
1年 パフォーマンス:
-12.69%
Mannkind Corp Stock (MNKD) Company Profile
MNKD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MNKD
Mannkind Corp
|
5.46 | 1.65B | 248.37M | 11.74M | 18.24M | 0.05 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
403.11 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
606.68 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
461.26 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
768.86 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
343.34 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-16 | 再開されました | H.C. Wainwright | Buy |
2025-04-10 | 開始されました | Mizuho | Outperform |
2025-02-10 | 開始されました | Wedbush | Outperform |
2024-12-20 | 開始されました | Wells Fargo | Overweight |
2024-12-19 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2024-09-09 | 再開されました | Leerink Partners | Outperform |
2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
2023-10-10 | 開始されました | Wedbush | Outperform |
2021-05-14 | 開始されました | RBC Capital Mkts | Sector Perform |
2019-12-24 | 開始されました | Oppenheimer | Outperform |
2019-10-25 | 開始されました | Cantor Fitzgerald | Overweight |
2019-05-14 | 開始されました | BTIG Research | Buy |
2019-03-04 | 開始されました | SVB Leerink | Outperform |
2019-02-22 | 開始されました | SVB Leerink | Outperform |
2018-02-28 | ダウングレード | Maxim Group | Hold → Sell |
2017-11-01 | ダウングレード | Maxim Group | Buy → Hold |
2017-10-10 | 開始されました | H.C. Wainwright | Buy |
2017-10-06 | 繰り返されました | Maxim Group | Buy |
2017-08-11 | 開始されました | Maxim Group | Buy |
2016-05-10 | 繰り返されました | Piper Jaffray | Underweight |
2016-05-10 | 繰り返されました | RBC Capital Mkts | Underperform |
2016-01-06 | 繰り返されました | Piper Jaffray | Underweight |
2016-01-06 | 繰り返されました | RBC Capital Mkts | Underperform |
2015-11-04 | ダウングレード | RBC Capital Mkts | Outperform → Underperform |
2015-09-09 | ダウングレード | Piper Jaffray | Neutral → Underweight |
2015-08-03 | 繰り返されました | RBC Capital Mkts | Outperform |
2015-05-11 | ダウングレード | JP Morgan | Neutral → Underweight |
2015-05-11 | 繰り返されました | MLV & Co | Hold |
2015-04-16 | 繰り返されました | RBC Capital Mkts | Outperform |
すべてを表示
Mannkind Corp (MNKD) 最新ニュース
Key metrics from MannKind Corporation’s quarterly dataCEO Change & Precise Entry and Exit Recommendations - newser.com
Is MannKind Corporation a good long term investmentSector ETF Performance & Take Advantage of Momentum Stocks - earlytimes.in
MannKind (MNKD) Appoints New Chief Medical Officer - GuruFocus
MNKD Appoints New Chief Medical Officer to Strengthen Leadership Team - GuruFocus
MannKind appoints Ajay Ahuja as chief medical officer - Investing.com
MannKind Corporation Appoints Dr. Ajay Ahuja as Chief Medical Officer - Quiver Quantitative
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer - Yahoo Finance
Will MannKind Corporation (NNFN) stock see insider accumulationJuly 2025 Rallies & Stock Timing and Entry Methods - newser.com
Is MannKind Corporation (NNFN) stock undervalued historically2025 Technical Overview & Stepwise Swing Trade Plans - newser.com
Why MannKind Corporation (NNFN) stock is trending on social mediaEntry Point & High Accuracy Swing Trade Signals - newser.com
Will a bounce in MannKind Corporation offer an exitEarnings Overview Summary & Community Verified Swing Trade Signals - newser.com
Non Tuberculous Mycobacterial Infections Market Dynamics - openPR.com
MannKind (NASDAQ:MNKD) Shares Down 5%Time to Sell? - MarketBeat
MannKind (NASDAQ:MNKD) Earns Buy Rating from HC Wainwright - MarketBeat
MannKind Corporation (NASDAQ:MNKD) Sees Significant Drop in Short Interest - MarketBeat
Insider Selling: MannKind (NASDAQ:MNKD) Insider Sells 47,000 Shares of Stock - MarketBeat
Goldman Sachs Group Inc. Sells 780,939 Shares of MannKind Corporation $MNKD - MarketBeat
MannKind (NASDAQ:MNKD) Trading Down 4.2%Should You Sell? - MarketBeat
MNKD: HC Wainwright & Co. Reiterates Buy Rating with $11 Target - GuruFocus
MannKind (MNKD) chief people officer sells $250,980 in stock By Investing.com - Investing.com UK
Insider Sell Alert: Stuart Tross Sells 47,000 Shares of MannKind Corp (MNKD) - GuruFocus
MannKind (MNKD) chief people officer sells $250,980 in stock - Investing.com
Hedge Fund Bets: Can MannKind Corporation outperform under higher oil prices2025 Earnings Surprises & AI Powered Market Entry Strategies - خودرو بانک
Hedge Fund Moves: Can MannKind Corporation stock double in the next year2025 Performance Recap & Growth Focused Entry Reports - khodrobank.com
Can MannKind Corporation outperform in the next rallyQuarterly Risk Review & Verified Swing Trading Watchlist - خودرو بانک
Weekly Recap: What is MannKind Corporations P E ratio telling usQuarterly Investment Review & Consistent Return Strategy Ideas - خودرو بانک
Analyst Calls: Can MannKind Corporation navigate macro headwindsGold Moves & Consistent Profit Trading Strategies - خودرو بانک
Jacobs Levy Equity Management Inc. Increases Stock Holdings in MannKind Corporation $MNKD - MarketBeat
Millennium Management LLC Purchases 2,375,198 Shares of MannKind Corporation $MNKD - MarketBeat
Mannkind Corp (MNKD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):